[1]李亮. 指南助力学科发展 疾病控制尚需努力——2014年结核病诊疗年度回顾. 中华医学信息导报,2015,30 (1):12-13. [2]向阳,优都斯·赛都拉,马金凤,等. 乌鲁木齐市某区2005—2009年门诊抗痨化疗肺结核患者不良反应情况分析. 现代预防医学,2011,38(15): 3060-3064. [3]Resende LS, Santos-Neto, ET. Risk factors associated with adverse reactions to antituberculosis drugs. J Bras Pneumol, 2015, 41(1):77-89. [4]Chung-Delgado K, Revilla-Montag A, Guillen-Bravo S, et al. Factors associated with anti-tuberculosis medication adverse effects: a case-control study in Lima, Peru. PLoS One, 2011,6(11): e27610. [5]雷建平, 吴雪琼, 张文宏. 抗结核药物所致肝损伤相关危险因素及临床处置对策. 中国防痨杂志, 2013, 35(11): 858-864. [6]Damasceno GS, Guaraldo L, Engstrom EM, et al. Adverse reactions to antituberculosis drugs in Manguinhos, Rio de Janeiro,Brazil. Clinics(Sao Paulo),2013, 68(3):329-337. [7]Lv X, Tang S, Xia Y, et al. Adverse reactions due to directly observed treatment strategy therapy in Chinese tuberculosis patients: a prospective study. PLoS One, 2013, 8(6): e65037. [8]邓国防,雷建平,邓群,等. 抗结核药物致超敏反应32例临床分析. 中国防痨杂志, 2014,36(1):21-24. [9]雷建平. 我国结核病化疗药物不良反应的防治现状与进展. 中国防痨杂志, 2014, 36(9): 774-782. [10]Costa GN, Magno LA, Santana CV, et al. Genetic interaction between NAT2, GSTM1, GSTT1,CYP2E1, and environmental factors is associated with adverse reactions to anti-tuberculosis drugs. Mol Diagn Ther, 2012,16(4):241-250. [11]张利. 抗结核药物不良反应报告结果分析. 中国现代药物应用, 2009, 21(3): 125-126. [12]苏长海,季晖,卢立山,等. 抗结核药物不良反应及其危害. 中国医院药学杂志, 2010,30 (2):176-178. |